The role of complement dysregulation in AMD mouse models

Advances in Experimental Medicine and Biology

Volumn 801, Issue , 2014, Pages 213-219

  Ding, Jin Dong ^a   Kelly, Una ^a   Groelle, Marybeth ^a   Christenbury, Joseph G ^a   Zhang, Wenlan ^a   Rickman, Catherine Bowes ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY EYE CENTER   (United States)

Author keywords

Age related macular degeneration; Alternative pathway; Complement; Complement factor H (CFH)

Indexed keywords

APOLIPOPROTEIN E4; COMPLEMENT; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3B RECEPTOR; COMPLEMENT FACTOR H; COMPLEMENT FACTOR I; COMPLEMENT INHIBITOR; COMPLEMENT RECEPTOR 1 RELATED PROTEIN Y; DECAY ACCELERATING FACTOR; DNA; MEMBRANE COFACTOR PROTEIN; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

AGE RELATED MACULAR DEGENERATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT DISORDER; COMPLEMENT FACTOR H GENE; COMPLEMENT GENE; COMPLEMENT INHIBITION; CROSS BREEDING; DISEASE MODEL; DISEASE PREDISPOSITION; DNA MODIFICATION; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; RISK FACTOR; ANIMAL; GENETICS; HUMAN; IMMUNOLOGY; KIDNEY DISEASE; RETINA MACULA DEGENERATION; REVIEW;

MUS;

ANIMALS; COMPLEMENT FACTOR H; COMPLEMENT SYSTEM PROTEINS; DISEASE MODELS, ANIMAL; HUMANS; KIDNEY DISEASES; MACULAR DEGENERATION; MICE; MICE, KNOCKOUT;

EID: 84904856715     PISSN: 00652598     EISSN: 22148019     Source Type: Book Series    
DOI: 10.1007/978-1-4614-3209-8_28     Document Type: Article

References (19)

1. Anderson DH, Mullins RF, Hageman GS, Johnson LV (2002) A role for local inflammation in the formation of drusen in the aging eye. Am J Ophthalmol 134(3):411-431
2. Hageman GS, Luthert PJ, Victor Chong NH, Johnson LV, Anderson DH, Mullins RF (2001) An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res 20(6):705-732
3. Johnson LV, Leitner WP, Staples MK, Anderson DH (2001) Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. Exp Eye Res 73(6):887-896
4. Zipfel PF, Lauer N, Skerka C (2010) The role of complement in AMD. Adv Exp Med Biol 703:9-24
5. Anderson DH, Radeke MJ, Gallo NB, Chapin EA, Johnson PT, Curletti CR, Hancox LS, Hu J, Ebright JN, Malek G, Hauser MA, Bowes Rickman C, Bok D, Hageman GS, Johnson LV (2010) The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited. Prog Retin Eye Res 29(2):95-112
6. Thurman JM, Holers VM (2006) The central role of the alternative complement pathway in human disease. J Immunol 176(3):1305-1310
7. Johnson PT, Betts KE, Radeke MJ, Hageman GS, Anderson DH, Johnson LV (2006) Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid. Proc Natl Acad Sci U S A 103(46):17456-17461
8. Pickering MC, Cook HT, Warren J, Bygrave AE, Moss J, Walport MJ, Botto M (2002) Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H. Nat Genet 31(4):424-428
9. Coffey PJ, Gias C, McDermott CJ, Lundh P, Pickering MC, Sethi C, Bird A, Fitzke FW, Maass A, Chen LL, Holder GE, Luthert PJ, Salt TE, Moss SE, Greenwood J (2007) Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction. Proc Natl Acad Sci U S A 104(42):16651-16656
10. Lundh von Leithner P, Kam JH, Bainbridge J, Catchpole I, Gough G, Coffey P, Jeffery G (2009) Complement factor h is critical in the maintenance of retinal perfusion. Am J Pathol 175(1):412-421
11. Foley S, Li B, Dehoff M, Molina H, Holers VM (1993) Mouse Crry/p65 is a regulator of the alternative pathway of complement activation. Eur J Immunol 23(6):1381-1384
12. Quigg RJ, He C, Lim A, Berthiaume D, Alexander JJ, Kraus D, Holers VM (1998) Transgenic mice overexpressing the complement inhibitor crry as a soluble protein are protected from antibody-induced glomerular injury. J Exp Med 188(7):1321-1331
13. Wyss-Coray T, Yan F, Lin AH, Lambris JD, Alexander JJ, Quigg RJ, Masliah E (2002) Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice. Proc Natl Acad Sci U S A 99(16):10837-10842
14. Ding JD, Lin J, Mace BE, Herrmann R, Sullivan P, Bowes Rickman C (2008) Targeting age-related macular degeneration with Alzheimer's disease based immunotherapies: anti-amyloid-beta antibody attenuates pathologies in an age-related macular degeneration mouse model. Vision Res 48(3):339-345
15. Johnson LV, Leitner WP, Rivest AJ, Staples MK, Radeke MJ, Anderson DH (2002) The Alzheimer's A beta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc Natl Acad Sci U S A 99(18):11830-11835
16. Ding JD, Kelly U, Smith SG, Groelle M, Bowes Rickman C (2011) Development and characterization of humanized complement factor H (CFH) transgenic mice. Association for Research in Vision and Ophthalmology:Abstract 958
17. Ufret-Vincenty RL, Aredo B, Liu X, McMahon A, Chen PW, Sun H, Niederkorn JY, Kedzierski W (2010) Transgenic mice expressing variants of complement factor H develop AMDlike retinal findings. Invest Ophthal Vis Sci 51(11):5878-5887
18. Malek G, Johnson LV, Mace BE, Saloupis P, Schmechel DE, Rickman DW, Toth CA, Sullivan PM, Bowes Rickman C (2005) Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration. Proc Natl Acad Sci U S A 102(33):11900-11905
19. Ding JD, Johnson LV, Herrmann R, Farsiu S, Smith SG, Groelle M, Mace BE, Sullivan P, Jamison JA, Kelly U, Harrabi O, Bollini SS, Dilley J, Kobayashi D, Kuang B, Li W, Pons J, Lin JC, Rickman CB (2011) Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration. Proc Natl Acad Sci U S A 108(28):E279-E287